Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease. [electronic resource]
Producer: 20170717Description: 414-425 p. digitalISSN:- 2219-2840
- Adalimumab -- administration & dosage
- Anti-Inflammatory Agents -- administration & dosage
- Azathioprine -- administration & dosage
- Drug Resistance -- immunology
- Drug Therapy, Combination
- Gastrointestinal Agents -- administration & dosage
- Humans
- Immunosuppressive Agents -- administration & dosage
- Inflammatory Bowel Diseases -- drug therapy
- Infliximab -- administration & dosage
- Monitoring, Immunologic
- Quality of Life
- Remission Induction
- Severity of Illness Index
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Withholding Treatment
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.